Skip to content
DilutionScan
20/20 Biolabs, Inc. logo
AIDX

20/20 Biolabs, Inc.

Sector: Services-Testing LaboratoriesIndustry: Medical - Care FacilitiesCountry: USExchange: Nasdaq

Mkt Cap
Float & O/S
Inst Own

DilutionScan read 20 of 20/20 Biolabs, Inc.'s SEC filings and found 8 warrant series, 11 convertibles, 1 equity line, 2 S-1 registrations and 6 completed offerings on file for AIDX. The latest dilution event on file is an offering on Jun 16, 2026. Analysis updated Oct 6, 2026.

Signal8 Summary

DilutionScan ProEvery instrument in full · $59/mo